Reviews
November 25, 2015
Vol. 80 No. 2 (2013): Cardiac series

The portopulmonary hypertension: an overview from diagnosis to treatment

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
1620
Views
43
Downloads

Authors

Portopulmonary hypertension (POPH) refers to the condition of pulmonary arterial hypertension (PAH) in association with portal hypertension. Among patients with portal hypertension, reported incidence rates of POPH range from 2 to 10% and long-term prognosis in cases of- POPH is poor. Fundamental issues of management of POPH include identification of patients likely to benefit from liver transplantation (LTx) and treatment with specific pulmonary vasodilators before and after LTx. This review presents as an overview of the current knowledge on the epidemiology, diagnosis, treatment and prognosis of patients with portopulmonary hypertension.

Altmetrics

Downloads

Download data is not yet available.

Citations

How to Cite



“The Portopulmonary Hypertension: An Overview from Diagnosis to Treatment”. 2015. Monaldi Archives for Chest Disease 80 (2). https://doi.org/10.4081/monaldi.2013.81.